NCT03651661View on ClinicalTrials.gov

Pupillography as Screening Tool for Brain Insulin Resistance

NACompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

July 3, 2018

Primary Completion Date

November 1, 2018

Study Completion Date

January 7, 2019

Conditions
Obesity
Interventions
DRUG

human insulin

human insulin administered as nasal spray

DRUG

placebo

placebo administered as nasal spray

DIAGNOSTIC_TEST

Pupillography

Autonomic tone will be adressed by pupillography using the F2D2 (Amtech Germany) device.

Trial Locations (1)

72076

University of Tuebingen, Department of Internal Medicine IV, Tübingen

All Listed Sponsors
lead

University Hospital Tuebingen

OTHER

NCT03651661 - Pupillography as Screening Tool for Brain Insulin Resistance | Biotech Hunter | Biotech Hunter